However, EIF4A3 phosphorylation in other tumors, such as renal cancer and malignant hematological diseases, has not been investigated, while the signaling pathways in HCC, breast cancer, lung cancer, and other tumors are poorly understood. Here, EIF4A3 is linked to breast cancer.